Sientra Inc (SIEN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sientra Inc (SIEN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6432
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices such as vaginal stents, reconstructive products and specialty products. It offers services such as simplified account setup, monthly credit card style, billing system, easy orders and returns, one-of-a-kind capcon care program, and free shipping and returns. The company develops aesthetics medicine and plastic surgery implants for cosmetic and reconstructive markets. It markets its products across the US. Sientra is headquartered in Santa Barbara, California, the US.

Sientra Inc (SIEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Sientra Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11
Venture Financing 12
Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12
Miramar Labs Raises USD2 Million in Venture Financing 13
Miramar Labs Raises USD1.2 Million in Financing Round 14
Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15
Miramar Labs Raises US$10 Million In Series D Financing 16
Miramar Labs Raises US$10 Million In Venture Financing 18
Miramar Labs US$5 Million In Venture Financing 19
Sientra Raises US$65 Million In Series C Financing 20
Private Equity 22
Miramar Labs Raises USD9 Million in Financing 22
Merger 24
Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24
Equity Offering 25
Sientra Raises USD115 Million in Public Offering of Shares 25
Sientra to Raise up to USD50 Million in Public Offering of Shares 27
Sientra Raises USD66 Million in Public Offering of Shares 28
Sientra Raises USD75 Million in IPO 30
Asset Transactions 31
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31
Acquisition 32
Sientra Acquires Miramar Labs 32
Sientra Inc – Key Competitors 34
Sientra Inc – Key Employees 35
Sientra Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Aug 07, 2018: Sientra reports second quarter 2018 financial results 37
May 09, 2018: Sientra Reports First Quarter 2018 Financial Results 39
Mar 13, 2018: Sientra Reports Fourth Quarter and Full Year 2017 Financial Results 40
Jan 08, 2018: Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue 42
Nov 07, 2017: Sientra Reports Third Quarter 2017 Financial Results 44
Aug 09, 2017: Sientra Reports Second Quarter 2017 Financial Results 45
May 09, 2017: Sientra Reports First Quarter 2017 Financial Results 46
Mar 14, 2017: Sientra Reports Fourth Quarter and Full Year 2016 Financial Results 47
Corporate Communications 49
Oct 06, 2017: Sientra Supports Reconstructive Breast Patients with Launch of Full Circle Grant Program and Revolutionary Portfolio of Tissue Expanders 49
Mar 01, 2017: Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain 50
Feb 07, 2017: Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors 51
Product News 52
Apr 25, 2018: Sientra to Showcase OPUS Breast Products and miraDry fresh Procedure at American Society of Aesthetic Plastic Surgeons Meeting 52
Apr 18, 2018: Sientra Receives FDA Approval of PMA Supplement 53
Sep 28, 2017: Comprehensive Analysis of Long-Term Safety Studies Reaffirms Smooth and Textured Breast Implants as Safe & Important Option for Patients Undergoing Aesthetic or Reconstructive Breast Surgery 54
Other Significant Developments 55
Aug 15, 2018: Sientra FULL CIRCLE grant applications open to U.S. Breast Cancer Organizations 55
Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57

List of Tables
Sientra Inc, Medical Equipment, Key Facts, 2017 2
Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sientra Inc, Deals By Market, 2012 to YTD 2018 9
Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11
Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12
Miramar Labs Raises USD2 Million in Venture Financing 13
Miramar Labs Raises USD1.2 Million in Financing Round 14
Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15
Miramar Labs Raises US$10 Million In Series D Financing 16
Miramar Labs Raises US$10 Million In Venture Financing 18
Miramar Labs US$5 Million In Venture Financing 19
Sientra Raises US$65 Million In Series C Financing 20
Miramar Labs Raises USD9 Million in Financing 22
Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24
Sientra Raises USD115 Million in Public Offering of Shares 25
Sientra to Raise up to USD50 Million in Public Offering of Shares 27
Sientra Raises USD66 Million in Public Offering of Shares 28
Sientra Raises USD75 Million in IPO 30
Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31
Sientra Acquires Miramar Labs 32
Sientra Inc, Key Competitors 34
Sientra Inc, Key Employees 35
Sientra Inc, Subsidiaries 36

List of Figures
Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sientra Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Sientra Inc (SIEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UCL Business PLC-医療機器分野:企業M&A・提携分析
    Summary UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the trans …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ADAMA Agricultural Solutions Ltd.:企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rockland Immunochemicals Inc (Rockland) is a biotechnology company that manufactures research tools for basic, applied and clinical research in functional genomics, drug discovery, gene therapy markets. The company’s products include collagen products, primary and secondary antibodies, Epi-P …
  • Tomey Corp:企業の戦略的SWOT分析
    Tomey Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Kikkoman Corp:企業の戦略・SWOT・財務分析
    Kikkoman Corp - Strategy, SWOT and Corporate Finance Report Summary Kikkoman Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Coats Group plc:企業の戦略・SWOT・財務情報
    Coats Group plc - Strategy, SWOT and Corporate Finance Report Summary Coats Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Europlasma SA (ALEUP):電力:M&Aディール及び事業提携情報
    Summary Europlasma SA (Europlasma) is a leading provider of clean technology and renewable energy solutions in Europe. The company along with its group companies offers plasma solutions to treat gas and hazardous waste and conducts waste disposal and power production from waste and biomass and recyc …
  • EnerNOC, Inc.-エネルギー分野:企業M&A・提携分析
    Summary EnerNOC, Inc. (EnerNOC), formerly EnerNOC, LLC, is a provider of energy intelligence software (EIS) and demand response solutions. The company’s EIS offers enterprise customers with Software-as-a-Service (SaaS) solutions with various areas of functionalities. It offers SaaS solutions to mana …
  • Yamato Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yamato Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Enea SA (ENA):企業の財務・戦略的SWOT分析
    Enea SA (ENA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sanofi-Aventis Korea Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis Korea Co Ltd (Sanofi-Aventis), a subsidiary of Sanofi is a developer, manufacturer and distributor of generic drugs and medical equipment. The company’s products include note vials lantus, lantus state solo star, she feeds the main vial la, feed her a solo star la shares, elro …
  • Legend Holdings Corporation (3396):企業の財務・戦略的SWOT分析
    Legend Holdings Corporation (3396) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Africa Israel Investments Ltd:企業の戦略・SWOT・財務情報
    Africa Israel Investments Ltd - Strategy, SWOT and Corporate Finance Report Summary Africa Israel Investments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Halozyme Therapeutics Inc (HALO):企業の財務・戦略的SWOT分析
    Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Verdezyne Inc-製薬・医療分野:企業M&A・提携分析
    Summary Verdezyne Inc (Verdezyne) is an industrial biotechnology company that develops and produces chemicals from renewable and non-food sources. The company’s products include adipic acid, dodecanedioic acid and sebacic acid. Its products are used in production of toothbrush bristles and fishing l …
  • ONGC Videsh Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary ONGC Videsh Ltd (OVL), a subsidiary of Oil and Natural Gas Corporation Limited, is an upstream oil and gas company that explores, develops and produces oil and gas from its international assets. It focuses on acquisition of exploratory and production licenses in foreign countries. The compan …
  • Purdue Pharma L.P.:企業の戦略・SWOT・財務情報
    Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report Summary Purdue Pharma L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆